Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes

被引:46
作者
Moura, Ines [1 ]
Spigaglia, Patrizia [1 ]
Barbanti, Fabrizio [1 ]
Mastrantonio, Paola [1 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
关键词
heterogeneity; reduced susceptibility; agar dilution; Etest; agar incorporation; REDUCED SUSCEPTIBILITY; RESISTANCE; DISEASE;
D O I
10.1093/jac/dks420
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibility to metronidazole was investigated in 81 Clostridium difficile strains, belonging to nine different PCR ribotypes, by three different laboratory methods. MICs for 81 C. difficile clinical isolates were determined by Etest, the agar dilution method (ADM) and the agar incorporation method (AIM). Twenty selected strains were also subjected to subinhibitory concentrations of metronidazole and the MIC heterogeneity was analysed in colonies from each strain that showed increased values before and after exposure to the antibiotic, using ADM and AIM. Overall, the MICs obtained by Etest were lower compared with those obtained by ADM and AIM, causing discrepancies in the categorization (as susceptible or having reduced susceptibility) of some strains. Reduced susceptibility to metronidazole was observed using both ADM and AIM, with higher MIC values by AIM in isolates belonging to PCR ribotypes 001 and 010. An increase in MICs after exposure to metronidazole was observed for strains belonging to these PCR ribotypes (by Etest and ADM, but not by AIM). In particular, MICs for colonies from strains belonging to either PCR ribotype 001 or 010 were less heterogeneous by AIM compared with by ADM, suggesting a better ability of AIM to detect strains with reduced susceptibility. These results suggest that the presence of C. difficile subpopulations with reduced susceptibility to metronidazole in the human intestine may be one of the factors responsible for reduced antibiotic efficacy in vivo. The possibility that higher MICs may have often gone unnoticed underlines the importance of choosing the best method for MIC determination and the necessity to monitor C. difficile susceptibility to metronidazole.
引用
收藏
页码:362 / 365
页数:4
相关论文
共 19 条
  • [1] Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
    Al-Nassir, Wafa N.
    Sethi, Ajay K.
    Nerandzic, Michelle M.
    Bobulsky, Greg S.
    Jump, Robin L. P.
    Donskey, Curtis J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (01) : 56 - 62
  • [2] Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish University Hospital
    Aspevall, O
    Lundberg, A
    Burman, LG
    Åkerlund, T
    Svenungsson, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1890 - 1892
  • [3] Emergence of reduced susceptibility to metronidazole in Clostridium difficile
    Baines, Simon D.
    O'Connor, Rachael
    Freeman, Jane
    Fawley, Warren N.
    Harmanus, Celine
    Mastrantonio, Paola
    Kuijper, Ed J.
    Wilcox, Mark H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1046 - 1052
  • [4] Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates
    Barbut, F.
    Mastrantonio, P.
    Delmee, M.
    Brazier, J.
    Kuijper, E.
    Poxton, I.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) : 1048 - 1057
  • [5] Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997
    Barbut, F
    Decré, D
    Burghoffer, B
    Lesage, D
    Delisle, F
    Lalande, V
    Delmée, M
    Avesani, V
    Sano, N
    Coudert, C
    Petit, JC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2607 - 2611
  • [6] Antibiotic-associated diarrhea
    Bartlett, JG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) : 334 - 339
  • [7] Clostridium difficile infection in Europe: a hospital-based survey
    Bauer, Martijn P.
    Notermans, Daan W.
    van Benthem, Birgit H. B.
    Brazier, Jon S.
    Wilcox, Mark H.
    Rupnik, Maja
    Monnet, Dominique L.
    van Dissel, Jaap T.
    Kuijper, Ed J.
    [J]. LANCET, 2011, 377 (9759) : 63 - 73
  • [8] Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing
    Bidet, P
    Barbut, F
    Lalande, V
    Burghoffer, B
    Petit, JC
    [J]. FEMS MICROBIOLOGY LETTERS, 1999, 175 (02) : 261 - 266
  • [9] Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel
    Bishara, J
    Bloch, Y
    Garty, M
    Behor, J
    Samra, Z
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (02) : 141 - 144
  • [10] Reduced susceptibility of Clostridium difficile to metronidazole
    Brazier, JS
    Fawley, W
    Freeman, J
    Wilcox, MH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 741 - 742